Search Details

Word: researcher (lookup in dictionary) (lookup stats)
Dates: during 1990-1999
Sort By: most recent first (reverse)


Usage:

...time, Koc's son told the Gazette, "Lately, Turkey has been not quite understood by the West--there is often a question in Westerners' minds about which direction Turkey will eventually take. We think it is important that Harvard--as a center of excellence--lead the way with research and teaching about the realities of Turkey today...

Author: By Vasugi V. Ganeshananthan and Erica B. Levy, CRIMSON STAFF WRITERSS | Title: Learning When To Say 'No' | 12/9/1999 | See Source »

...used to being able to get up from our desks and research any problem that comes up right then and there. There are countless volumes that we need access to," Webster said...

Author: By J. HAL Simon, CRIMSON STAFF WRITER | Title: Library Offices May Relocate; Workers Protest | 12/8/1999 | See Source »

Right now the bill is 'in study' in the Joint Committee on Commerce and Labor--which means it won't move without more research...

Author: By Kiratiana E. Freelon, CRIMSON STAFF WRITER | Title: Rep. Barrios Gets Results In Brief House Term | 12/8/1999 | See Source »

...everyone agrees. The Food and Drug Administration currently exercises almost total control over the information flow from clinical trials, and while biotech companies certainly don't want their human research subjects to die, they do want to keep a tight lid on their proprietary research. "This is a highly commercial undertaking," says TIME correspondent Dick Thompson, "and most of the tests to date have failed." Still, companies that do hit on the right combination are spinning so much genetic straw into pure gold, and they don't want their competitors learning Rumplestiltskin's secrets on their dime...

Author: /time Magazine | Title: Here's a Blockbuster Fight: It's NIH vs. FDA | 12/8/1999 | See Source »

...never a pretty sight when medical ethics collide head-on with the multibillion-dollar business of disease research. Cover your eyes, because that's exactly what's happening this week in Washington, D.C., where the National Institutes of Health is holding a three-day hearing on the white-hot topic of gene therapy research. In the wake of the September death of 18-year-old gene therapy recipient Jesse Gelsinger, the NIH has a clear request for public safety: Open human clinical trials to public scrutiny and report any medical problems or setbacks immediately...

Author: /time Magazine | Title: Here's a Blockbuster Fight: It's NIH vs. FDA | 12/8/1999 | See Source »

Previous | 6 | 7 | 8 | 9 | 10 | 11 | 12 | 13 | 14 | 15 | 16 | 17 | 18 | 19 | 20 | 21 | 22 | 23 | 24 | 25 | 26 | Next